ADAMTS5 and Alzheimer disease: As two OA-related factors, ADAMTS4 and ADAMTS5 were enhanced in the NS group compared to the control group and were reduced by AD-MSCs and SH injection for either 3 or 8 weeks (Figures 4(j) and 4(k) and Figure S2J-S2K).